BANK OF MONTREAL /CAN/ - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 58 filers reported holding OBALON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$0710.0%0.00%
Q1 2019$0
-100.0%
71
-87.4%
0.00%
Q4 2018$1,000
-50.0%
5620.0%0.00%
Q3 2018$2,000
+100.0%
5620.0%0.00%
Q2 2018$1,000
-75.0%
562
-54.5%
0.00%
Q1 2018$4,0001,235
+1639.4%
0.00%
Q4 2017$0
-100.0%
710.0%0.00%
Q3 2017$1,000710.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$23,380,0006.09%
Tamarack Advisers, LP 547,536$5,218,0003.20%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,149,0000.28%
Moisand Fitzgerald Tamayo, LLC 6,875$281,0000.17%
FORMULA GROWTH LTD 108,998$1,039,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 351,284$3,348,0000.15%
KORNITZER CAPITAL MANAGEMENT INC /KS 423,390$4,035,0000.07%
TIVERTON ASSET MANAGEMENT LLC 123,800$1,179,0000.07%
Granite Investment Partners, LLC 108,758$1,036,0000.06%
Bellevue Group AG 48,000$457,0000.05%
View complete list of OBALON THERAPEUTICS INC shareholders